Big Move For Evofem Biosciences, Inc.
Evofem Biosciences, Inc. (EVFM:NASDAQ) rocketted at $1.07, a gain of 187.7%. On Mon, Jun 27, 2022, EVFM:NASDAQ touched a New 2-Week High of $1.07. The stock appeared on our News Catalysts scanner on Mon, Jun 27, 2022 at 03:52 PM in the 'MISCELLANEOUS' category. From Mon, Jun 13, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Jan 12, 2022 at $8.1 with a volume of 3M+.
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 187.71%
- Acutus Medical Inc. (AFIB:NASDAQ), 87.59%
- Epizyme, Inc. (EPZM:NASDAQ), 55.14%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 51.39%
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 48.81%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 42.39%
- InflaRx N.V. (IFRX:NASDAQ), 38.28%
- Kiromic BioPharma Inc. (KRBP:NASDAQ), 36.14%
- Visionary Education Technology Holdings Group Inc. (VEDU:NASDAQ), 33.16%
- Aspira Women's Health Inc. (AWH:NASDAQ), 32.39%